Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Health Affairs (Project Hope)
|
November 11, 2008
Disorientation: finding the north
Ashish Chintakuntlawar
Current Treatment Options in Oncology
|
January 19, 2026
Systemic Therapy for Salivary Gland Cancers: A Review of Targeted and Chemotherapeutic Approaches
Justin M Hintze, Ashish Chintakuntlawar
Leukemia & Lymphoma
|
June 3, 2014
Toxoplasmosis in patients with hematologic malignancies
Ashish Chintakuntlawar, Michael Kidd, Aref Al-Kali, et al.
Current Oncology Reports
|
April 14, 2022
Emerging Disparities in Prevention and Survival Outcomes for Patients with Head and Neck Cancer and Recommendations for Health Equity
Manisha Salinas, Ashish Chintakuntlawar, Ivie Arasomwan, et al.
Journal of Women'S Health (2002)
|
September 22, 2017
The Impact of Antithrombin Deficiency on Women's Reproductive Health Experiences and Healthcare Decision-Making
Ariela L Marshall, Juliana Perez Botero, Aneel A Ashrani, et al.
Plos One
|
June 4, 2009
Evidence of molecular evolution driven by recombination events influencing tropism in a novel human adenovirus that causes epidemic keratoconjunctivitis
Michael P Walsh, Ashish Chintakuntlawar, Christopher M Robinson, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
July 15, 2020
Human Papillomavirus-Associated Anogenital Pathology in Females With HPV-Positive Oropharyngeal Squamous Cell Carcinoma
Alyssa Larish, Linda Yin, Gretchen Glaser, et al.
International Forum of Allergy & Rhinology
|
April 6, 2022
Long-term oncologic outcomes in esthesioneuroblastoma: An institutional experience of 143 patients
Ryan A McMillan, Jamie J Van Gompel, Michael J Link, et al.
The Lancet. Oncology
|
September 4, 2025
De-escalated adjuvant radiotherapy versus standard adjuvant treatment for human papillomavirus-associated oropharyngeal squamous cell carcinoma (MC1675): a phase 3, open-label, randomised controlled trial
Daniel Ma, Katharine Price, Eric Moore, et al.
JAMA Oncology
|
April 26, 2019
Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis
Yucai Wang, Shouhao Zhou, Fang Yang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Health Affairs (Project Hope)
|
November 11, 2008
Disorientation: finding the north
Ashish Chintakuntlawar
Current Treatment Options in Oncology
|
January 19, 2026
Systemic Therapy for Salivary Gland Cancers: A Review of Targeted and Chemotherapeutic Approaches
Justin M Hintze, Ashish Chintakuntlawar
Leukemia & Lymphoma
|
June 3, 2014
Toxoplasmosis in patients with hematologic malignancies
Ashish Chintakuntlawar, Michael Kidd, Aref Al-Kali, et al.
Current Oncology Reports
|
April 14, 2022
Emerging Disparities in Prevention and Survival Outcomes for Patients with Head and Neck Cancer and Recommendations for Health Equity
Manisha Salinas, Ashish Chintakuntlawar, Ivie Arasomwan, et al.
Journal of Women'S Health (2002)
|
September 22, 2017
The Impact of Antithrombin Deficiency on Women's Reproductive Health Experiences and Healthcare Decision-Making
Ariela L Marshall, Juliana Perez Botero, Aneel A Ashrani, et al.
Plos One
|
June 4, 2009
Evidence of molecular evolution driven by recombination events influencing tropism in a novel human adenovirus that causes epidemic keratoconjunctivitis
Michael P Walsh, Ashish Chintakuntlawar, Christopher M Robinson, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
July 15, 2020
Human Papillomavirus-Associated Anogenital Pathology in Females With HPV-Positive Oropharyngeal Squamous Cell Carcinoma
Alyssa Larish, Linda Yin, Gretchen Glaser, et al.
International Forum of Allergy & Rhinology
|
April 6, 2022
Long-term oncologic outcomes in esthesioneuroblastoma: An institutional experience of 143 patients
Ryan A McMillan, Jamie J Van Gompel, Michael J Link, et al.
The Lancet. Oncology
|
September 4, 2025
De-escalated adjuvant radiotherapy versus standard adjuvant treatment for human papillomavirus-associated oropharyngeal squamous cell carcinoma (MC1675): a phase 3, open-label, randomised controlled trial
Daniel Ma, Katharine Price, Eric Moore, et al.
JAMA Oncology
|
April 26, 2019
Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis
Yucai Wang, Shouhao Zhou, Fang Yang, et al.
Page
of 2